Home > News > Altair Nanotechnologies Announces Successful Renalan Test Results
December 8th, 2005
Altair Nanotechnologies Announces Successful Renalan Test Results
Abstract:
Altair Nanotechnologies Inc. (NASDAQ: ALTI) today reported the completion of successful animal testing for its Renalan™ product line of nano-structured phosphate binders.
Source:
marketwire
Bookmark:
Nanomedicine
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Materials
INSCX™ exchange announces substantial increase in capital designated to provide Trade Finance for registered Nanomaterial Producers May 21st, 2013
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Kinks and curves at the nanoscale: New research shows 'perfect twin boundaries' are not so perfect May 20th, 2013
Advancements and developments of solid-state nanopores sensors May 16th, 2013
Announcements
JPK reports on single molecule research at IISER Pune in India using AFM and CellHesion techniques May 21st, 2013
Imec and GLOBALFOUNDRIES collaborate to advance high-density memory technology: STT-MRAM offers enhanced performance and scalability for embedded and standalone applications May 21st, 2013
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013